Dexmedetomidine and clonidine: A review of their pharmacodynamy to define their role for sedation in intensive care patients;Dexmédétomidine et clonidine : Revue de leurs propriétés pharmacodynamiques en vue de définir la place des agonistes alpha-2 adrénergiques dans la sédation en réanimation

Annales Francaises d'Anesthesie et de Reanimation

Volumn 31, Issue 11, 2012, Pages 876-896

  Pichot, C ^a   Longrois, D ^b   Ghignone, M ^c   Quintin, L ^a  

^a University Claude Bernard Lyon 1   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Critical Care Medicine   (United States)

Author keywords

Alpha 2 adrenergic agonists; Clonidine; Critical care medicine; Dexmedetomidine; Diastolic function; Intensive care medicine; Oxygen consumption; Respiratory drive; Sedation; Systolic function; Vascular reactivity; Weaning

Indexed keywords

CATECHOLAMINE; CLONIDINE; DEXMEDETOMIDINE;

BLOOD VESSEL REACTIVITY; CRITICAL ILLNESS; DELIRIUM; DIASTOLE; HUMAN; IMPEDANCE; INTENSIVE CARE; KIDNEY FUNCTION; LUNG ARTERY; OXYGEN CONSUMPTION; PHARMACODYNAMICS; PRESSORECEPTOR REFLEX; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DRIVE; SEDATION; SHORT SURVEY; SYSTOLE;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANALGESICS; CARDIOVASCULAR SYSTEM; CLONIDINE; DEEP SEDATION; DEXMEDETOMIDINE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; RESPIRATION;

EID: 84869144008     PISSN: 07507658     EISSN: 17696623     Source Type: Journal    
DOI: 10.1016/j.annfar.2012.07.018     Document Type: Short Survey

References (218)

1. Sauder P., Andreoletti M., Cambonie G., Capellier G., Feissel M., Gall O., et al. Sedation and analgesia in intensive care. French Critical Care Society. Ann Fr Anesth Reanim 2008, 27:541-551.
2. Kollef M.H., Levy N.T., Ahrens T.S., Schaiff R., Prentice D., Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998, 114:541-548.
3. Brochard L. Less sedation in intensive care: the pendulum swings back. Lancet 2010, 375:436-438.
4. Payen J.F., Bru O., Bosson J.L., Lagrasta A., Novel E., Deschaux I., et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med 2001, 29:2258-2263.
5. Girard T.D., Kress J.P., Fuchs B.D., Thomason J.W.W., Schweikert W.D., Pun B.T., et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing controlled trial): a randomised controlled trial. Lancet 2008, 371:126-134.
6. Triltsch A.E., Welte M., von H.P., Grosse J., Genahr A., Moshirzadeh M., et al. Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study. Crit Care Med 2002, 30:1007-1014.
7. Strom T., Martinussen T., Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet 2010, 375:475-480.
8. Kress J.P., Pohlman A.S., O'Connor M.F., Hall J.B. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000, 342:1471-1477.
9. Ely E.W., Inouye S.K., Bernard G.R., Gordon S., Francis J., May L., et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). J Am Med Assoc 2001, 286:2703-2710.
10. Shehabi Y., Riker R.R., Bokesch P.M., Wisemandle W., Shintani A., Ely E.W. Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients. Crit Care Med 2010, 38:2311-2318.
11. Pandharipande P.P., Shintani A.K., Peterson J., Pun B.T., Wilkinson G.R., Dittus R.S., et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006, 104:21-26.
12. Shehabi Y., Ruettimann U., Adamson H., Innes R., Ickeringill M. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med 2004, 30:2188-2196.
13. Shelly M.P. Dexmedetomidine: a real innovation or more of the same?. Br J Anaesth 2001, 87:677-678.
14. Bernard J.M., Quintin L., Pinaud M. Clonidine : du traitement de l'hypertension artérielle à l'utilisation en anesthésie. I, principaux effets et mécanisme d'action de la clonidine. Ann Fr Anesth Reanim 1990, 9:59-66.
15. Bernard J.M., Quintin L., Pinaud M. Clonidine : du traitement de l'hypertension artérielle à l'utilisation en anesthésie. II. Utilisation périopératoire. Ann Fr Anesth Reanim 1990, 9:423-432.
16. Pichot C., Ghignone M., Quintin L. Dexmedetomidine and clonidine: from second- to first-line sedative agents in the critical care setting?. J Intensive Care Med 2012, 27:219-237. [Epub 2011 Apr 27].
17. Pandharipande P.P., Pun B., Herr D.I., Maze M., Girard T.D., Miller R.R., et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. J Am Med Assoc 2007, 298:2644-2653.
18. Riker R.R., Shehabi Y., Bokesch P.M., Ceraso D., Wisemandle W., Koura F., et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. J Am Med Assoc 2009, 301:489-499.
19. Ghignone M., Quintin L., Duke P.C., Kehler C.H., Calvillo O. Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endotracheal intubation. Anesthesiology 1986, 64:36-42.
20. Ghignone M., Calvillo O., Quintin L. Anesthesia and Hypertension: the effect of clonidine on perioperative hemodynamics and isoflurane requirements. Anesthesiology 1987, 67:3-10.
21. Ghignone M., Noe C., Calvillo O., Quintin L. Anesthesia for ophthalmic surgery in the elderly: the effects of clonidine on intraocular pressure, perioperative hemodynamics and anesthetic requirements. Anesthesiology 1988, 68:707-716.
22. Metz G., Nebel B. Clonidine in severe alcohol withdrawal delirium. Fortschrift Medizin 1983, 101:1260-1264.
23. Bhana N., Goa K.L., McClellan K.J. Dexmedetomidine. Drugs 2000, 59:263-268.
24. Knaus A.E., Muthig V., Schickinger S., Moura E., Beetz N., Gilsbach R., et al. Alpha2-adrenoceptor subtypes--unexpected functions for receptors and ligands derived from gene-targeted mouse models. Neurochem Int 2007, 51:277-281.
25. Nelson L.E., Lu J., Guo T., Saper C.B., Franks N.P., Maze M. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003, 98:428-436.
26. Wing L.M., Reid J.L., Davies D.S., Dargie H.J., Dollery C.T. Apparent resistance to hypotensive effect of clonidine. Br Med J 1977, 1:136-138.
27. Erkonen G., Lamb F., Tobias J.D. High-dose dexmedetomidine-induced hypertension in a child with traumatic brain injury. Neurocrit Care 2008, 9:366-369.
28. Robertson D., Goldberg M.R., Hollister A.S., Wade D., Robertson R.M. Clonidine raises blood pressure in severe idiopathic orthostatic hypotension. Am J Med 1983, 74:193-200.
29. Arndts D. New aspects of the clinical pharmacology of clonidine. Chest 1983, 83:397-400.
30. De Wolf A.M., Fragen R.J., Avram M.J., Fitzgerald P.C., Rahimi-Danesh F. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg 2001, 93:1205-1209.
31. Venn R.M., Karol M.D., Grounds R.M. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 2002, 88:669-675.
32. Davies D.S., Wing L.M.H., Reid J.L., Neill E., Tipett P., Dollery C.T. Pharmacokinetics and concentration-effect relationships of intravenous and oral clonidine. Clin Pharmacol Ther 1977, 21:593-601.
33. Hoffmann B.B., Lefkowitz R.J. Catecholamines, Sympathomimetic drugs and adrenergic receptor antagonists. Goodmans and Gilman's. The pharmacological basis of therapeutics 1996, 199-248. McGraw-Hill, New York. J.G. Hardman, L.E. Limbird (Eds.).
34. Quintin L., Bouilloc X., Butin E., Bayon M.C., Brudon J.R., Levron J.C., et al. Clonidine for aortic surgery in hypertensive patients: a double blind controlled randomized study. Anesth Analg 1996, 83:687-695.
35. Ebert T.J., Hall J.E., Barney J.A., Uhrich T.D., Colinco M.D. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000, 93:382-394.
36. Head G.A. Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension. J Hypertension 2003, 21:701-703.
37. Hashimoto J., Chonan K., Aoki Y., Ugajin T., Yamaguchi J., Nishimura T., et al. Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension: evaluation using home-based blood pressure measurements. J Hypertension 2003, 21:805-811.
38. Bousquet P., Feldman J., Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther 1984, 230:232-236.
39. Guyenet P. Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites?. Am J Physiol 1997, 273:R1580-R1584.
40. Tamsen A., Gordh T. Epidural clonidine produces analgesia. Lancet 1984, 2:231-232.
41. Venn R.M., Bradshaw C.J., Spencer R., Brealey D., Caudwell E., Naughton C., et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999, 54:1136-1142.
42. Kooner J.S., Peart W.S., Mathias C.J. The haemodynamic and hormonal responses after clonidine occur independently of sedation in essential hypertension. Br J Clin Pharmacol 1989, 28:249-255.
43. Saunier C.F., Akaoka H., de La Chapelle B., Charlety P.J., Chergui K., Chouvet G., et al. Activation of brain noradrenergic neurons during recovery from halothane anesthesia: persistence of phasic activation after clonidine. Anesthesiology 1993, 79:1072-1082.
44. Miyazaki S., Uchida S., Mukai J., Nishihara K. Clonidine effects on all-night human sleep: opposite action of low- and medium-dose clonidine on human NREM-REM sleep proportion. Psychiatry Clin Neurosci 2004, 58:138-144.
45. Huupponen E., Maksimow A., Lapinlampi P., Sarkela M., Saastamoinen A., Snapir A., et al. Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiol Scand 2008, 52:289-294.
46. Drummond J.C., Dao A.V., Roth D.M., Cheng C.R., Atwater B.I., Minokadeh A., et al. Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology 2008, 108:225-232.
47. Maze M. Dexmedetomidine: a viewpoint. Drugs 2000, 59:269.
48. Venn R.M., Grounds R.M. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 2001, 87:684-690.
49. Ruokonen E., Parviainen I., Jakob S.M., Nunes S., Kaukonen M., Shepherd S.T., et al. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med 2009, 35:282-290.
50. Martin E., Ramsay G., Mantz J., Sum-Ping S.T. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 2003, 18:29-41.
51. MacLaren R., Forrest L.K., Kiser T.H. Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters. Pharmacotherapy 2007, 27:351-359.
52. Aston-Jones G., Cohen J.D. Adaptative gain and the role of the locus coeruleus-norepinephrine system in optimal performance. J Comp Neurol 2005, 493:99-110.
53. Arnsten A.F., Goldman-Rakic P.S. Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science 1985, 230:1273-1276.
54. Onesti G., Bock K.D., Heimsoth V., Kim K.E., Merguet P. Clonidine: a new antihypertensive agent. Am J Cardiol 1971, 28:74-83.
55. Paalzow G., Paalzow L. Clonidine antinociceptive activity: effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat. Naunyn Schmiedebergs Arch Pharmacol 1976, 292:119-126.
56. Skingle M., Hayes A.G., Tyers M.B. Antinociceptive activity of clonidine in the mouse, rat and dog. Life Sci 1982, 31:1123-1132.
57. Calvillo O., Ghignone M. Presynaptic effect of clonidine on unmyelinated afferent fibers in the spinal cord of the cat. Neurosci Lett 1986, 64:335-339.
58. Marwaha J., Kehne J.H., Commisaris R.L., Lakovski J., Shaw W., Davis M. Spinal clonidine inhibits neural firing in locus coeruleus. Brain Res 1983, 276:379-382.
59. Hood D.D., Mallak K.A., Eisenach J.C., Tong C. Interaction between intrathecal neostigmine and epidural clonidine in human volunteers. Anesthesiology 1996, 85:315-325.
60. Mohanty P.K., Sowers J.R., McNamara C., Thames M.D. Reflex vasoconstrictor responses to cardiopulmonary baroreceptor unloading, head-up tilt and cold pressor testing in elderly mild-to moderate hypertensives: effect of clonidine. J Cardiovasc Pharmacol 1987, 10:S135-S137.
61. Kauppila T., Kemppainen P., Tanila H., Pertovaara A. Effect of systemic medetomidine, an alpha-2 adrenoceptor agonist, on experimental pain in humans. Anesthesiology 1991, 74:3-8.
62. De Kock M., Wiederkehr P., Laghmiche A., Scholtes J.L. Epidural clonidine used as the sole analgesic agent during and after abdominal surgery. Anesthesiology 1997, 86:285-292.
63. Ramsay M.A., Luterman D.L. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology 2004, 101:787-790.
64. Hofer R.E., Sprung J., Sarr M.G., Wedel D.J. Anesthesia for a patient with morbid obesity using dexmedetomidine without narcotics. Can J Anesth 2005, 52:176-180.
65. Ramsay M.A., Saha D., Hebeler R.F. Tracheal resection in the morbidly obese patient: the role of dexmedetomidine. J Clin Anesth 2006, 18:452-454.
66. Gold M.S., Redmond D.E., Kleber H.D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet 1978, 2:599-602.
67. Glassman A.H., Jackson W.K., Walsh B.T., Roose S.P., Rosenfeld B. Cigarette craving, smoking withdrawal and clonidine. Science 1984, 226:864-866.
68. Spies C.D., Dubisz N., Neumann T., Blum S., Muller C., Rommelspacher H., et al. Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial. Crit Care Med 1996, 24:414-422.
69. Bohrer H., Bach A., Layer M., Werming P. Clonidine as a sedative adjunct in intensive care. Intensive Care Med 1990, 16:265-266.
70. Freshwater-Turner D., Udy A., Lipman J., Deans R., Stuart J., Boots R., et al. Autonomic dysfunction in tetanus - what lessons can be learnt with specific reference to alpha-2 agonists?. Anaesthesia 2007, 62:1066-1070.
71. Sutton D.N., Tremlett M.R., Woodcock T.E., Nielsen M.S. Management of autonomic dysfunction in severe tetanus: the use of magnesium sulphate and clonidine. Intensive Care Med 1990, 16:75-80.
72. Liatsi D., Tsapas B., Pampori S., Tsagourias M., Pneumatikos I., Matamis D. Respiratory, metabolic and hemodynamic effects of clonidine in ventilated patients presenting with withdrawal syndrome. Intensive Care Med 2009, 35:275-281.
73. Martin J., Parsch A., Franck M., Wernecke K.D., Fischer M., Spies C. Practice of sedation and analgesia in German intensive care units: results of a national survey. Crit Care 2005, 9:R117-R123.
74. Tonner P.H., Weiler N., Paris A., Scholz J. Sedation and analgesia in the intensive care unit. Curr Opin Anaesthesiol 2003, 16:113-121.
75. Rubino A.S., Onorati F., Caroleo S., Galato E., Nucera S., Amantea B., et al. Impact of clonidine administration on delirium and related respiratory weaning after surgical correction of acute type-A aortic dissection: results of a pilot study. Intern Cardiovasc Thorac Surg 2010, 10:58-62.
76. Maldonado J.R., Wysong A., van der Starre P.J., Block T., Miller C., Reitz B.A. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics 2009, 50:206-217.
77. Venn R.M., Hell J., Grounds R.M. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000, 4:302-308.
78. Tobias J.D. Dexmedetomidine: applications in pediatric ciritical care and pediatric anesthesiology. Pediatr Crit Care Med 2007, 2007:115-131.
79. Connor D.F., Fletcher K.E., Swanson J.M. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1999, 38:1551-1559.
80. Cohen D.J., Detlor J., Young J.G., Shaywitz B.A. Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry 1980, 37:1350-1357.
81. Freedman R., Kirch D., Bell J., Adler L.E., Pecevich M., Pachtman E., et al. Clonidine treatment of schizophrenia. Double-blind comparison to placebo and neuroleptic drugs. Acta Psychiatr Scand 1982, 65:35-45.
82. McEntee W.J., Mair R.G. Memory enhancement in Korsakoff's psychosis by clonidine: further evidence for a noradrenergic deficit. Ann Neurol 1980, 7:466-470.
83. Voituron N., Hilaire G., Quintin L. Dexmedetomidine and clonidine induce long-lasting activation of the respiratory rhythm generator of neonatal mice: possible implication for critical care. Respir Physiol Neurobiol 2012, 180:132-140.
84. Bailey P.L., Speng R.J., Johnson G.K., Eldredge S.J., East K.A., East T.D., et al. Respiratory effects of clonidine alone and combined with morphine in humans. Anesthesiology 1991, 74:43-48.
85. Ooi R., Pattison J., Feldman S.A. The effects of intravenous clonidine on ventilation. Anaesthesia 1991, 46:632-633.
86. Belleville J.P., Ward D.S., Bloor B.C., Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992, 77:1125-1133.
87. Benhamou D., Veillette Y., Narchi P., Ecoffey C. Ventilatory effects of premedication with clonidine. Anesth Analg 1991, 73:799-803.
88. Penon C., Ecoffey C., Cohen S.E. Ventilatory response to carbon dioxide after epidural clonidine injection. Anesth Analg 1991, 72:761-764.
89. Issa F.G. Effect of clonidine in obstructive sleep apnea. Am Rev Respir Dis 1992, 145:435-439.
90. Takahashi H., Nishikawa T., Mizutani T., Handa F. Oral clonidine premedication decreases energy expenditure in human volunteers. Can J Anesth 1997, 44:268-272.
91. Quintin L., Viale J.P., Annat G., Hoen J.P., Butin E., Cottet-Emard J.M., et al. Oxygen uptake after major abdominal surgery: effect of clonidine. Anesthesiology 1991, 74:236-241.
92. Pawlik M.T., Hansen E., Waldhauser D., Selig C., Kuehnel T.S. Clonidine premedication in patients with sleep apnea syndrome: a randomized, double-blind, placebo-controlled study. Anesth Analg 2005, 101:1374-1380.
93. Flacke J.W., Flacke W.E. Clonidine prevention of myocardial ischemia during cardiac surgery: will this change outcome?. J Cardiothorac Vasc Anesth 1993, 7:383-385.
94. Clonidine and non-invasive ventilation in children 2005, European Respiratory Society. J. Bhatt, R. Primhak, A. Mayer (Eds.).
95. Akada S., Takeda S., Yoshida Y., Nakazato K., Mori M., Hongo T., et al. The efficacy of dexmedetomidine in patients with noninvasive ventilation: a preliminary study. Anesth Analg 2008, 107:167-170.
96. Chrysostomou C., Di F.S., Manrique A.M., Schmitt C.G., Orr R.A., Casta A., et al. Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med 2006, 7:126-131.
97. Grundstrom N., Andersson R.G.G. Inhibition of the cholinergic neurostransmission in human airways via prejunctionnal alpha-2 adrenoceptors. Acta Physiol Scand 1985, 125:513-517.
98. Lindgren B.R., Ekstrom T., Andersson R.G.G. The effects of inhaled clonidine in patients with asthma. Am Rev Respir Dis 1986, 134:266-269.
99. Dinh Xuan A.T., Lockhart A. Bronchial effects of alpha 2-adrenoceptor agonists and of other antihypertensive agents in asthma. Am J Med 1989, 87:34S-37S.
100. Groeben H., Mitzner W., Brown R.H. Effects of the alpha-2 adrenoceptor agonist dexmedetomidine on bronchoconstriction in dogs. Anesthesiology 2004, 100:359-363.
101. Tobias J.D., Berkenbosch J.W., Russo P. Additional experience with dexmedetomidine in pediatric patients. South Med J 2003, 96:871-875.
102. Takasaki Y., Kido T., Semba K. Dexmedetomidine facilitates induction of non-invasive positive pressure ventilation for acute respiratory failure in patients with severe asthma. J Anesth 2009, 23:147-150.
103. Lubbe N., Bornscheuer A., Kirchner E. The effect of clonidine on the intra-pulmonary right-to-left shunting in one-lung ventilation in the dog. Anaesthetist 1991, 40:391-396.
104. Kernan S., Rehman S., Meyer T., Bourbeau J., Caron N., Tobias J.D. Effects of dexmedetomidine on oxygenation during one-lung ventilation for thoracic surgery in adults. J Minim Access Surg 2011, 7:227-231.
105. Sun M.K., Guyenet P. Effect of clonidine and gamma-aminobutyric acid on the discharges of medullo-spinal sympathoexcitatory neurons in the rat. Brain Res 1986, 368:1-17.
106. Mermet C., Quintin L. Effect of clonidine on the catechol metabolism in the rostral ventrolateral medulla: an in vivo electrochemical study. Eur J Pharmacol 1991, 204:105-107.
107. Kobinger W., Pichler L. The central modulatory effect of clonidine on the cardiodepressor reflex after suppression of synthesis and storage of noradrenaline. Eur J Pharmacol 1975, 30:56-62.
108. Heusch G., Schipke J., Thamer V. Clonidine prevents the sympathetic initiation and aggravation of poststenotic myocardial ischemia. J Cardiovasc Pharmacol 1985, 7:1176-1182.
109. Lawrence C.J., Prinzen F.W., de Lange S. The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand. Anesth Analg 1996, 82:544-550.
110. Zochowski R.J., Lada W. Intravenous clonidine in acute myocardial infarction in men. Intern J Cardiol 1984, 6:189-201.
111. Quintin L., Cicala R., Kent M., Thomsen B. Effect of clonidine on myocardial ischemia: a double-blind pilot trial. Can J Anesth 1993, 40:85-86.
112. Ghignone M., Calvillo O., Quintin L., Noe C., Caple S. Clonidine: a new pulmonary vasodilator. Crit Care Med 1986, 14:344.
113. But A.K., Ozgul U., Erdil F., Gulhas N., Toprak H.I., Durmus M., et al. The effects of pre-operative dexmedetomidine infusion on hemodynamics in patients with pulmonary hypertension undergoing mitral valve replacement surgery. Acta Anaesthesiol Scand 2006, 50:1207-1212.
114. Nathan A.T., Marino B.S., Hanna B., Nicolson S.C. Novel use of dexmedetomidine in a patient with pulmonary hypertension. Paediatr Anaesth 2008, 18:782-784.
115. Toyama H., Wagatsuma T., Ejima Y., Matsubara M., Kurosawa S. Cesarean section and primary pulmonary hypertension: the role of intravenous dexmedetomidine. Intern J Obstet Anesth 2009, 18:262-267.
116. Northam W.J., Mobley P. Clonidine pretreatment enhances the sensitivity of the beta-noradrenergic receptor coupled adenylate cyclase system in astrocytes. Eur J Pharmacol 1985, 113:153-154.
117. Zoukos Y., Thomaides T., Pavitt D.V., Leonard J.P., Cuzner M.L., Mathias C.J. Upregulation of beta adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects. Clin Autonom Res 1992, 2:165-170.
118. Quiroz A.C., Eilen S.D., Sander G.E., Giles T.D. The effect of intravenous clonidine hydrochloride on the isolated forearm venous segment in heart failure. Chest 1983, 83(Suppl.):430-433.
119. Guthrie G.P., Kotchen T.A. Effects of oral clonidine on baroreflex function in patients with essential hypertension. Chest 1983, 83:327-328.
120. Dollery C.T., Harington M., Hodge J.V. Haemodynamic studies with methyldopa: effect on cardiac output and response to pressor amines. Br Heart J 1963, 25:670-676.
121. Parlow J., Sagnard P., Begou G., Viale J.P., Quintin L. The effects of clonidine on sensitivity to phenylephrine and nitroprusside in patients with essential hypertension recovering from surgery. Anesth Analg 1999, 88:1239-1243.
122. De Kock M., Laterre P.F., Van Obbergh L., Carlier M., Lerut J. The effects of intraoperative intravenous clonidine on fluid requirements, hemodynamic variables, and support during liver transplantation: a prospective, randomized study. Anesth Analg 1998, 86:468-476.
123. Venn R.M., Newman P.J., Grounds R.M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med 2003, 29:201-207.
124. Herr D.L., Sum-Ping S.T., England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 2003, 17:576-584.
125. Pandharipande P.P., Sanders R.D., Girard T.D., McGrane S., Thompson J.L., Shintani A.K., et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care 2010, 14:R38.
126. Quintin L. Alpha-2 adrenoceptor agonists and sepsis: improved survival?. Crit Care 2010, 14:429.
127. Dodd-o J.M., Breslow M.J., Dorman T., Rosenfeld B.A. Preserved sympathetic response to hypotension despite perioperative alpha-2 agonist administration. Anesth Analg 1997, 84:1208-1210.
128. Pichot C., Mathern P., Khettab F., Ghignone M., Geloen A., Quintin L. Increased pressor response to noradrenaline during septic shock following clonidine?. Anaesth Intensive Care 2010, 38:784-785.
129. Motz W., Ippisch R., Strauer B.E. The role of clonidine in hypertensive heart disease. Influence on myocardial contractility and left ventricular afterload. Chest 1983, 83:433-435.
130. Giles T.D., Iteld B.J., Mautner R.K., Rognoni P.A., Dillenkoffer R.L. Short-term effects of intravenous clonidine in congestive heart failure. Clin Pharmacol Ther 1981, 30:724-728.
131. Hermiller J.B., Magorien R.D., Leithe M.E., Unverferth D.V., Leier C.V. Clonidine in congestive heart failure: a vasodilator with negative inotropic effects. Am J Cardiol 1983, 51:791-795.
132. Manolis A.J., Olympios C., Sifaki M., Handanis S., Bresnahan M., Gavras I., et al. Suppressing sympathetic activation in congestive heart failure: a new therapeutic strategy. Hypertension 1995, 26:719-724.
133. Olivari M.T., Levine T.B., Cohn J.N. Acute hemodynamic and hormonal effects of central vs peripheral sympathetic inhibition in patients with congestive heart failure. J Cardiovasc Pharmacol 1986, 8:973-978.
134. Magorien R.D., Hermiller J.B., Unverferth D.V., Leier C.V. Regional hemodynamic effects of clonidine in congestive heart failure. J Cardiovasc Pharmacol 1985, 7:91-96.
135. Moorman A.J., Stratton J.R., Levy W.C. Clonidine therapy in patients with heart failure improves exercise efficiency, functional class and symptoms. Intern J Cardiol 2011, 150:372-373.
136. Foresti A., Massari F.M., Lotto A. Hemodynamic effects of clonidine in patients with acute myocardial infarction complicated by hypertension. J Cardiovasc Pharmacol 1986, 8:S30-S32.
137. Mitrovic V., Hallier E., Kuschke H.J. The hemodynamic effects of clonidine in patients with grade III to IV hypertension. J Cardiovasc Pharmacol 1986, 8:S51-S55.
138. Stefanadis C., Manolis A., Dernellis J., Tsioufis C., Tsiamis E., Gavras I., et al. Acute effect of clonidine on left ventricular pressure-volume relation in hypertensive patients with diastolic heart dysfunction. J Hum Hypertens 2001, 15:635-642.
139. Quintin L., Ghignone M. Risks associated with perioperative use of alpha-2 adrenoceptors agonists. Alpha-2 adrenoceptor agonists in anaesthesia and intensive care 2000, 347-368. Harcourt, London. J. Scholz, P.H. Tonner (Eds.).
140. Gillon J.Y., Quintin L., Ghignone M., Pujol J.F. Clonidine modulates the ventrolateral medullary catechol metabolic hyperactivity induced by hypotension. Brain Res 1987, 418:157-163.
141. Tobias J.D. Bradycardia during dexmedetomidine and therapeutic hypothermia. J Intensive Care Med 2008, 23:403-408.
142. Pohl-Schickinger A., Lemmer J., Hubler M., exi-Meskishvili V., Redlin M., Berger F., et al. Intravenous clonidine infusion in infants after cardiovascular surgery. Paediatr Anaesth 2008, 18:217-222.
143. Arenas-Lopez S., Riphagen S., Tibby S.M., Durward A., Tomlin S., Davies G., et al. Use of oral clonidine for sedation in ventilated paediatric intensive care patients. Intensive Care Med 2004, 30:1625-1629.
144. Czaja A.S., Zimmerman J.J. The use of dexmedetomidine in critically ill children. Pediatr Crit Care Med 2009, 10:381-386.
145. Gerlach A.T., Dasta J.F., Steinberg S., Martin L.C., Cook C.H. A new dosing protocol reduces dexmedetomidine-associated hypotension in critically ill surgical patients. J Crit Care 2009, 24:568-574.
146. Ter Minassian A., Beydon L., Decq P., Bonnet F. Changes in cerebral hemodynamics after a single dose of clonidine in severely head-injured patients. Anesth Analg 1997, 84:127-132.
147. Aryan H.E., Box K.W., Ibrahim D., Desiraju U., Ames C.P. Safety and efficacy of dexmedetomidine in neurosurgical patients. Brain Inj 2006, 20:791-798.
148. Jorden V.S., Pousman R.M., Sanford M.M., Thorborg P.A., Hutchens M.P. Dexmedetomidine overdose in the perioperative setting. Ann Pharmacother 2004, 38:803-807.
149. Meyer C., Cambray R. One hundred times the intended dose of caudal clonidine in three pediatric patients. Paediatr Anaesth 2008, 18:888-890.
150. Toader E., Cividjian A., Rentero N., McAllen R.M., Quintin L. Cardioinhibitory actions of clonidine assessed by cardiac vagal motoneuron recordings. J Hypertension 2008, 26:1169-1180.
151. Toader E., Cividjian A., Quintin L. Recruitment of cardiac parasympathetic activity: effects of clonidine on cardiac vagal motoneurones, pressure lability and cardiac baroreflex slope in rats. Br J Anaesth 2009, 102:322-330.
152. McAllen R.M., Spyer K.M. The baroreceptor input to cardiac vagal motoneurones. J Physiol 1978, 282:365-374.
153. Harron D.W.G., Kobinger W. Facilitation of the Bezold-Jarisch reflex by central stimulation of alpha-2 adrenoceptors in dogs. Naunyn Schmiedebergs Arch Pharmacol 1984, 325:193-197.
154. Clementy J., Castagne D., Wicker P., Dallochio M., Bricaud H. Study of the electrophysiologic properties of clonidine administered intravenously. J Cardiovasc Pharmacol 1986, 8:S24-S29.
155. Schwartz E., Friedman E., Mouallem M., Farfel Z. Sinus arrest associated with clonidine therapy. Clin Cardiol 1988, 11:53-54.
156. Niarchos A.P., Baksi A.K. Treatment of severe hypertension and hypertensive emergencies with intravenous clonidine hydrochloride. Postgrad Med J 1973, 49:908-913.
157. Ingersoll-Weng E., Manecke GRTP.A. Dexmedetomidine and cardiac arrest. Anesthesiology 2004, 100:738-739.
158. Chrysostomou C., Komarlu R., Lichstenstein S., Shiderly D., Arora G., Orr R., et al. Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease. Intensive Care Med 2011, 2010:836-842.
159. Lal S., Tolis G., Martin S.B., Brown G.M., Guyda H. Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men. J Clin Endocrinol Metabol 1975, 41:827-832.
160. Peltonen G., Scalzo R., Schweder M., Larson D., Luckasen J., Irwin D., et al. Sympathetic inihibition attenuates hypoxia-induced insulin resistance in helathy adult humans. J Physiol 2012, 590:2801-2809.
161. Roulot D., Moreau R., Gaudin C., Bacq Y., Braillon A., Hadengue A., et al. Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites. Gastroenterology 1992, 102:1309-1318.
162. Lenaerts A., Codden T., Meunier J.C., Henry J.P., Ligny G. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system. Hepatology 2006, 44:844-849.
163. Esler M., Dudley F., Jennings G., Debinski H., Lambert G., Jones P., et al. Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis. Ann Intern Med 1992, 116:446-455.
164. Singhal S., Baikati K.K., Jabbour I.I., Anand S. Management of refractory ascites. Am J Ther 2012, 19:121-132.
165. Rubinoff M.J., Piccione P.R., Holt P.R. Clonidine prolongs human small intestine transit time: use of the lactulose-breath hydrogen test. Am J Gastroenterol 1989, 84:372-374.
166. Morali G.A., Braverman D.Z., Lissi J., Goldstein R., Jacobsohn W.Z. Effect of clonidine on gallbladder contraction and small bowel transit time in insulin-treated diabetics. Am J Gastroenterol 1991, 86:995-999.
167. Iirola T., Vilo S., Aantaa R., Wendelin-Saarenhovi M., Neuvonen P.J., Scheinin M., et al. Dexmedetomidine inhibits gastric emptying and oro-coecal transit time in healthy volunteers. Br J Anaesth 2011, 106:522-527.
168. Bear R., Steer K. Pseudo-obstruction due to clonidine. Br Med J 1976, 1:197.
169. Stieger D.S., Cantieni R., Frutiger A. Acute colonic pseudoobstruction (Ogilvie's syndrome) in two patients receiving high dose clonidine for delirium tremens. Intensive Care Med 1997, 23:780-782.
170. Hokfelt B., Hedeland H., Dymling J.F. Studies on catecholamines, renin and aldosterone following catapresan R (2-(2,6-dichlor-phenylamine)-2-imidazoline hdrochloride) in hypertensive patients. Eur J Pharmacol 1970, 10:389-397.
171. Campese V.M., Romoff M., Telfer N., Weidmann P., Massry S.G. Role of sympathetic nerve inhibition and body sodium-state in the antihypertensive action of clonidine in essential hypertension. Kidney Intern 1980, 18:351-357.
172. Liepert D.J., Townsend G.E. Improved hemodynamic and renal function with clonidine in coronary artery bypass grafting. Anesth Analg 1990, 70:S240.
173. Kulka P.J., Tryba M., Zenz M. Preoperative alpha-2 adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med 1996, 24:947-952.
174. Mertes N., Goeters C., Kuhmann M., Zander J.F. Postoperative alpha 2-adrenergic stimulation attenuates protein catabolism. Anesth Analg 1996, 82:258-263.
175. Kulka P.J., Tryba M., Reimer T., Weisser H. Clonidine prevents tissue-malperfusion during extracorporal circulation. Anesth Analg 1996, 82:S254.
176. von Dossow V., Baehr N., Moshirzadeh M., von H.C., Braun J.P., Hein O.V., et al. Clonidine attenuated early proinflammatory response in T-cell subsets after cardiac surgery. Anesth Analg 2006, 103:809-814.
177. Weber M.D., Thammasitboon S., Rosen D.A. Acute discontinuation syndrome from dexmedetomidine after protracted use in a pediatric patient. Paediatr Anaesth 2008, 18:87-88.
178. Wunsch H., Kress J.P. A new era for sedation in ICU patients. J Am Medl Assoc 2009, 301:542-544.
179. Shehabi Y., Botha J.A., Ernest D., Freebairn R.C., Reade M., Roberts B.L., et al. Clinical application, the use of dexmedetomidine in intensive care sedation. Crit Care Shock 2010, 13:40-50.
180. Kariya N., Shindoh M., Nishi S., Yukioka H., Asada A. Oral clonidine to control hypertension after head injury. EurJ Emerg Med 1999, 6:77-79.
181. Payen D., Quintin L., Plaisance P., Chiron B., Lhoste F. Head injury: clonidine decreases plasma catecholamines. Crit Care Med 1990, 18:392-395.
182. Grille P., Biestro A., Farina G., Miraballes R. Effects of dexmedetomidine on intracranial hemodynamics in severe head injured patients. Neurocirugia (Astur) 2005, 16:411-418.
183. Eker C., Asgeirsson B., Grande P.O., Schalen W., Nordstrom C.H. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation. Crit Care Med 1998, 26:1881-1886.
184. Naredi S., Eden E., Zall S., Stephensen H., Rydenhag B. A standardized neurosurgical neurointensive therapy directed toward vasogenic edema after severe traumatic brain injury: clinical results. Intensive Care Med 1998, 24:446-451.
185. Stahl N., Ungerstedt U., Nordstrom C.H. Brain energy metabolism during controlled reduction of cerebral perfusion pressure in severe head injuries. Intensive Care Med 2001, 27:1215-1233.
186. Grande P.O., Asgeirsson B., Nordstrom C.H. Volume-targeted therapy of increased intracranial pressure: the Lund concept unifies surgical and non-surgical treatments. Acta Anaesthesiol Scand 2002, 46:929-941.
187. Joris J., Banache M., Bonnet F., Sessler D.I., Lamy M. Clonidine and ketanserin both are effective treatment for postanesthetic shivering. Anesthesiology 1993, 79:532-539.
188. Arpino P.A., Kalafatas K., Thompson B.T. Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit. J Clin Pharmacol Ther 2008, 33:25-30.
189. Jaber S., Petrof B.J., Jung B., Chanques G., Berthet J.P., Rabuel C., et al. Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am J Respir Crit Care Med 2011, 183:364-371.
190. Levine S., Nguyen T., Taylor N., Friscia M.E., Budak M.T., Rothenberg P., et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med 2008, 358:1327-1335.
191. Pichot C., Geloen A., Ghignone M., Quintin L. Alpha-2 agonists to reduce vasopressor requirements in septic shock?. Med Hypotheses 2010, 75:652-656.
192. Senzaki H., Ishido H., Iwamoto Y., Taketazu M., Kobayashi T., Katogi T., et al. Sedation of hypercyanotic spells in a neonate with tetralogy of Fallot using dexmedetomidine. J Pediatr 2008, 84:377-380.
193. Easley R.B., Tobias J.D. Pro: dexmedetomidine should be used for infants and children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2008, 22:147-151.
194. Hammer G.B. Con: dexmedetomidine should not be used for infants and children during cardiac surgery. J Cardiothorac Vasc Anesth 2008, 22:152-154.
195. Smith I.M., Kennedy L.R., Regnç-Karlsson M.H., Johnson V.L., Burmeister L.F. Adrenergic mechanisms in infection. III: alpha and beta-receptor blocking agents in treatment. Am J Clin Nutr 1977, 30:1285-1288.
196. Hofer S., Steppan J., Wagner T., Funke B., Lichtenstern C., Martin E., et al. Central sympatholytics prolong survival in experimental sepsis. Crit Care 2009, 13:R11.
197. Taniguchi T., Kidani Y., Kanakura H., Takemoto Y., Yamamoto K. Effects of dexmedetomidine on mortality rate and inflamatory response to endotoxin-induced shock in rats. Crit Care Med 2004, 32:1322-1326.
198. Taniguchi T., Kurita A., Kobayashi K., Yamamoto K., Inaba H. Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. J Anesth 2008, 22:221-228.
199. Venn R.M., Bryant A., Hall G.M., Grounds R.M. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth 2001, 86:650-656.
200. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
201. Meisel C., Schwab J.M., Prass K., Meisel A., Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nate Rev Neurosci 2005, 2005:775-786.
202. Esmaoglu A., Ulgey A., Akin A., Boyaci A. Comparison between dexmedetomidine and midazolam for sedation of eclampsia patients in the intensive care unit. J Crit Care 2009, 24:551-555.
203. Oliver M.F., Goldman L., Julian D.G., Holme I. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary disease. Anesthesiology 1999, 91:951-961.
204. Wallace A.W., Galindez D., Salalieh A., Layug E.L., Lazo E.A., Haratonik K.A., et al. Effect of clonidine on cardiovascular morbidity and mortality after non cardiac surgery. Anesthesiology 2004, 101:284-293.
205. Wijeysundera D.N., Naik J.S., Beattie S. Alpha-2 adrenergic agonists to prevent cardiovascular complications. Am J Med 2003, 114:752.
206. Stevens R.D., Burri H., Tramer M.R. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 2003, 97:623-633.
207. Gregorakos L., Kerezoudi E., Dimopoulos G., Thomaides T. Management of blood pressure instability in severe tetanus: the use of clonidine. Intensive Care Med 1997, 23:893-895.
208. Cleaveland C.R., Rangno R.E., Shand D.G. A standardized isoproterenol sensitivity test. Arch Intern Med 1972, 130:47-52.
209. Segal I.S., Vickery R.G., Walton J.K., Doze V.A., Maze M. Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha-2 adrenergic receptor. Anesthesiology 1988, 69:818-823.
210. Haeusler G. Clonidine-induced inhibition of sympathetic nerve activity: no indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn Schmiedebergs Arch Pharmacol 1974, 286:97-111.
211. Schlicker E., Armah B.I., Gothert M. Central presynaptic alpha-2 autoreceptors are involved in the blood pressure-lowering effect of monoxidine. J Cardiovasc Pharmacol 1990, 16:15-22.
212. Sleight P., West M.J., Korner P.I., Oliver J.R., Chalmers J.P., Robinson J.L. The action of clonidine on the baroreflex control of heart rate in conscious animals and man and on single aortic baroreceptor discharge in the rabbit. Arch Intern Pharmacodyn Ther 1975, 214:4-11.
213. Cividjian A., Toader E., Wesseling K.H., Karemaker J., McAllen R.M., Quintin L. Effect of clonidine on cardiac baroreflex delay in humans and rats. Am J Physiol 2011, 300:R949-R957.
214. Parlow J., Begou G., Sagnard P., Cottet-Emard J.M., Levron J.C., Annat G., et al. Cardiac baroreflex during the postoperative period in patients with hypertension: effect of clonidine. Anesthesiology 1999, 90:681-692.
215. Aston-Jones G., Ennis M., Pieribone V.A., Nickell W.T., Shipley M.T. The brain nucleus coeruleus: restricted afferent control of a broad efferent network. Science 1986, 234:734-737.
216. Chiu K.M., Lin T.Z., Lu C.W., Wang S.J. Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by alpha-2 adrenoceptor agonist dexmedetomidine. Eur J Pharmacol 2011, 670:137-147.
217. Laudenbach V., Mantz J., Lagercrantz H., Desmonts J.M., Evrard P., Gressens P. Effects of alpha(2)-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine. Anesthesiology 2002, 96:134-141.
218. Aston-Jones G.E., Bloom F.E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1981, 1:876-886.